NCT04916158

Brief Summary

Today, prosthetic replacement for osteoarthritis of the knee is a frequent surgery. In France, nearly 100,000 knee arthroplasties are performed each year . Over the last two decades, there has been growing interest in performing single compartment knee replacement (SKR) surgery in patients with isolated single compartment osteoarthritis. The explanation lies in faster recovery, less postoperative pain and less morbidity compared to total knee arthroplasty (TKR) . Pain control is one of the major elements of outpatient management of CKD . Prosthetic knee surgery is very painful, the median pain is rated at 5 out of 10 and on average we use 32 milligrams of morphine . The efficiency of the adductor canal block is effective in this context, it avoids the motor block obtained by the femoral block, therefore interesting for ambulatory management in view of a resumption of the fast walking foreseen for the patient. The IPACK (interspace between popliteal artery and the capsule posterior knee) is designed to block the small sensory branches of the sciatic nerve that pass through this space without affecting the motor components. The IPACK block provides analgesia only for the posterior knee and would probably be ineffective alone for postoperative analgesia It is therefore often performed with an adductor canal block for multimodal analgesia. This block is performed in several facilities, and data are increasingly emerging on its effectiveness . Thus, based on the recommendations of the French Society of Anesthesia and Resuscitation, on improved rehabilitation after heavy orthopedic surgery on the lower limb published in 2019 the objective of this study is to evaluate the relevance of a protocol concerning prosthetic knee replacement (PUC) in ambulatory care, based on optimized pain control.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
200

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2021

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 7, 2021

Completed
19 days until next milestone

First Submitted

Initial submission to the registry

January 26, 2021

Completed
4 months until next milestone

First Posted

Study publicly available on registry

June 7, 2021

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 31, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 31, 2022

Completed
Last Updated

June 7, 2021

Status Verified

January 1, 2021

Enrollment Period

1.1 years

First QC Date

January 26, 2021

Last Update Submit

June 3, 2021

Conditions

Keywords

IPACK, knee arthroplasty, ambulatory

Outcome Measures

Primary Outcomes (1)

  • Test get up and go test measured from day 0 to day 3. The test is successful if the score is >1

    Day 0 to Day 3

Secondary Outcomes (3)

  • evaluation of the patient's recovery by the QOR-15 questionnaire at 24 and 48 hours,

    24 and 48 hours

  • evaluation of visual analogue pain scale up to Day 5 postoperatively

    day 5

  • evaluation of morphine consumption up to Day 5 postoperatively

    day 5

Eligibility Criteria

Age18 Years - 85 Years
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients with programmed SKR

You may qualify if:

  • Patients with programmed SKR,
  • \>18 and \< 85 years of age,
  • Score ASA 1-2,
  • No cognitive impairment,
  • No thromboembolic TCDA,
  • Without CI to local anesthetics, analgesics,
  • Accepting outpatient care
  • No opposition formulated

You may not qualify if:

  • \<18 years and \>85 years
  • Patients under legal protection (guardianship, curatorship, ...)
  • Refusal to participate
  • Support for a total knee prosthesis,
  • Emergency surgery or revision surgery,
  • ASA3-4,
  • SAOS not fitted,
  • Allergy or hypersensitivity to local anesthetics,
  • Outpatient discharge criteria not met.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHRU de Brest

Brest, 29609, France

RECRUITING

Central Study Contacts

Claire-Marine Grayo, Doctorat

CONTACT

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 26, 2021

First Posted

June 7, 2021

Study Start

January 7, 2021

Primary Completion

January 31, 2022

Study Completion

January 31, 2022

Last Updated

June 7, 2021

Record last verified: 2021-01

Data Sharing

IPD Sharing
Will share

All collected data that underlie results in a publication

Shared Documents
STUDY PROTOCOL
Time Frame
Data will be available beginning one year and ending five years following the publication
Access Criteria
Data access requests will be reviewed by the internal committee of Brest UH. Requestors will be required to sign and complete a data access agreement.

Locations